Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphopenia 1Esophageal Neoplasms 1

Interventions

Specimen Handling 118Magnetic Resonance Spectroscopy 115Cyclophosphamide 98pembrolizumab 82Radiotherapy 78Nivolumab 67Cisplatin 64fludarabine 59Biopsy 55Carboplatin 53Standard of Care 45Radiosurgery 43Dexamethasone 40Gemcitabine 39Radiation 37Paclitaxel 36venetoclax 35Rituximab 35Cytarabine 35Bevacizumab 35Surveys and Questionnaires 34Doxorubicin 33fludarabine phosphate 31Temozolomide 31Radiotherapy, Intensity-Modulated 30Capecitabine 30Practice Guidelines as Topic 29Blood Specimen Collection 29Interviews as Topic 28Fluorouracil 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × SARS-CoV-2 inactivated vaccines × 30 days × Clear all
NCT06181656 2026-05-20

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

M.D. Anderson Cancer Center

Recruiting
80 enrolled
Gastrointestinal

Esophageal Neoplasms, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡